Pulling SEC filings + quote and writing the call…

GSK plc
Next earnings Jul 28, 2026 · consensus $0.46 EPS, $8.48B rev
Mixed signals in the latest filings.
GSK plc shows limited reported revenue.
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001131399, latest 6-K filed 2026-06-26) · EODHD · as of 6/20/2026, 7:30:55 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2025-12-11 | GSK plc 10% owner | Buy | 1.47M @ $19.00 | $27.9M |
| 2024-09-27 | GSK plc 10% owner | Buy | 2.79M @ $8.00 | $22.3M |
| 2023-12-07 | GSK plc 10% owner | Buy | 3.30M @ $5.00 | $16.5M |
| 2022-09-16 | GSK PLC Insider | Disposed (J) | 9.64M @ $9.75 | $94.0M |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
1044 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.